Veterans with MS: does ocrelizumab help with brain fog and tiredness?
NCT ID NCT07181811
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 30 veterans with multiple sclerosis who have been taking ocrelizumab for at least a year. Researchers will test their memory, attention, and fatigue levels at the start, 6 months, and 12 months using questionnaires and cognitive tests. The goal is to see how long-term ocrelizumab therapy relates to thinking skills and tiredness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ocrelizumab
- What this could lead to
- If successful, this could help doctors better understand and manage fatigue and cognitive issues in MS patients on ocrelizumab.
- What could go wrong
- This is a small, observational study with no control group, so results may not apply broadly. It only measures changes, not whether ocrelizumab causes them.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
John D. Dingell VA Medical Center
Detroit, Michigan, 48201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?